Pediatrics
Latest News
FDA accepts application for topical molluscum treatment
A new drug application for berdazimer gel 10.3% for the treatment of molluscum will be reviewed by the FDA.
Latest News
Be vigilant about suspected cases of measles, expert advises
“This is a re-emerging viral infection that dermatologists must recognize,” Dr. Adelaide A. Hebert said.
Latest News
How to help pediatricians apply peanut allergy guidelines
Researchers are testing whether a two-part intervention, which includes training videos and a clinical decision support tool, helps pediatricians...
Latest News
Can skin care aid use of diabetes devices?
Regular use of lipid-rich skin creams can reduce eczema in children who use insulin pumps and continuous glucose monitors to manage type 1...
Latest News
Topical or intralesional cidofovir an option for recalcitrant warts
Some studies have suggested that one in three children in primary school suffers from warts.
Feature
What’s holding back physicians from prescribing biosimilars? Four specialties weigh in
Physicians surveyed from four different specialties reported that they were generally comfortable prescribing biosimilars, but greater discounts...
Latest News
How to manage isotretinoin’s bothersome mucocutaneous side effects
Often underappreciated is the potential for chronic dry eye and other ocular changes, Dr. John S. Barbieri said.
Latest News
How prevalent is pediatric melanoma?
As in adults, the stage correlates strongly with survival, and distant metastases carry a poor prognosis.
Pediatric Dermatology Consult
An 11-year-old boy presents with small itchy bumps on the wrists, face, arms, and legs
An 11-year-old boy presents with small, itchy bumps on his face and extremities.
Latest News
FDA expands oral JAK abrocitinib to adolescents with AD
The indication has been expanded for those aged 12-17 whose disease is not adequately controlled with other systemic drugs, including biologics,...
Latest News
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
The analysis included 2,338 patients with psoriasis aged 17 years and younger who started new treatment with ustekinumab, etanercept, or...